Skip to content

   Pharma Publications

Neuropsychopharmacology
  • FGF21 analogue PF-05231023 on alcohol consumption and neuronal activity in the nucleus accumbens
    Published on 2025-05-26
    1 month ago
  • Cortical myelin mapping in antipsychotic medication-naïve, first-episode psychosis patients
    Published on 2025-05-23
    1 month ago
  • The Tailtag: A multi-mouse tracking system to measure social dynamics in complex environments
    Published on 2025-05-22
    1 month ago
  • DLPFC: The Decade circLe CCNP Family Cohort
    Published on 2025-05-21
    1 month ago
  • Stress-related genetic factors modify the effect of socioeconomic status on cardiovascular risk
    Published on 2025-05-21
    1 month ago
  • The efficacy of elevating anandamide via inhibition of fatty acid amide hydrolase (FAAH) combined with internet-delivered cognitive behavioral therapy in the treatment of post-traumatic stress disorder: a randomized, placebo-controlled clinical trial
    Published on 2025-05-17
    2 months ago
  • Sleep patterns predicting stress resilience are dependent on sex
    Published on 2025-05-17
    2 months ago
« Previous 1 … 3 4 5 6 7 … 143 Next »
Journal of Psychopharmacology
  • Corrigendum: Is psychedelic use associated with cancer? Interrogating a half-century-old claim using contemporary population-level data
    Published on 2025-05-16
    2 months ago
  • Retraction: The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis
    Published on 2025-05-16
    2 months ago
  • Circadian rhythmicity in prepulse inhibition of the acoustic startle response: A study of chronotype and time-of-day effects in young healthy adults
    Published on 2025-05-15
    2 months ago
  • CYP1A2 genotype-dependent effects of smoking on mirtazapine serum concentrations
    Published on 2025-05-12
    2 months ago
  • Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review
    Published on 2025-05-12
    2 months ago
  • The effects of menthol content on the abuse liability of smokeless tobacco in a randomized crossover trial
    Published on 2025-05-08
    2 months ago
  • Brexpiprazole augmentation and mitochondrial gene expression changes in major depressive disorder
    Published on 2025-05-06
    2 months ago
« Previous 1 … 3 4 5 6 7 … 123 Next »
European Neuropsychopharmacology
  • Racial and ethnic diversity in zuranolone and brexanolone clinical trials for postpartum depression: A cross-sectional analysis of ClinicalTrials.gov
    Published on 2025-04-11
    3 months ago
  • Creatine as a treatment for depression: A brain bioenergetics perspective
    Published on 2025-04-11
    3 months ago
  • Rethinking suicide prediction: From static risk factors to dynamic models
    Published on 2025-04-11
    3 months ago
  • Commentary on the Article “Optimizing differential diagnostics and identifying transdiagnostic treatment targets using virtual reality”
    Published on 2025-04-11
    3 months ago
  • Comparing PANSS-6 and PANSS-30 for clinical and functional outcomes in first-episode psychosis: A 2-year follow-up in a Spanish cohort
    Published on 2025-04-11
    3 months ago
  • Predicting 10-year risk of chronic kidney disease in lithium-treated patients with bipolar disorder: A risk model development and internal cross-validation study
    Published on 2025-04-11
    3 months ago
  • Negative Symptoms in Schizophrenia: The Placebo Effect as a Barrier to Drug Development?
    Published on 2025-04-11
    3 months ago
« Previous 1 … 3 4 5 6 7 … 144 Next »

   Pharma Pub